The College of American Pathologists has updated 14 Cancer Protocols, mandating the Breast Phyllodes Tumor protocol for accreditation and revising breast biomarker and GIST molecular testing criteria, according to CAP.
A 2025 Westgard QC survey finds daily out-of-control quality control events reported by 33% of labs worldwide and 45% in the US, raising concerns about current QC practices amid rising operational pressures.
Waters has launched the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometer with up to five lasers and 78 detectors, enabling analysis of over 50 single-cell characteristics with less than 10% variation, according to the company.
Vanta Diagnostics reports a 40% reduction in accessioning errors and up to 72% efficiency gains after implementing AI-assisted document processing.
General practitioner requests for AMH fertility tests rose more than 13-fold from 2011 to 2021, despite research showing these tests cannot predict natural conception, according to a Flinders University study of 1.4 million health records.
